In this new article by Contract Pharma, Asma Patel the VP of Global and Scientific Consulting - Drug Product at Quotient Sciences discusses the best best practices for solving complex formulation challenges while Maintaining Speed Through the Lifecycle.
How Clinically Informed Formulation Development Reduces Risk
Complex small molecule formulations offer the potential for more targeted drug delivery, but challenges around solubility, bioavailability, scale-up, and manufacturability can slow development.
Read the full article on Contract Pharma's website here.